• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,093
80
61
58
47

COUNTRY

56
17
8
6
5

CATEGORIES

  • 89
  • 129
  • 71
  • 72
  • 43
  • 43
  • 21
  • 16
  • 20
  • 22

PRICE

547
798
1,611
2,577

PUBLISHED

94
299
723
2,577

PRODUCT TYPE

2,431
71
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Global Lung Cancer Therapeutics Market 2015-2019

About Lung Cancer Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed...

November 2014
FROM

Dendritic Cell and CAR-T Therapies, 2014 - 2024

The focus of drug developers is gradually moving towards immunotherapeutics, which make use of the body’s own immune system or its components to fight cancer. It is a relatively new concept, with the...

November 2014
FROM
Global Oncology Market - Trends, Forecast and Pipeline Analysis Global Oncology Market - Trends, Forecast and Pipeline Analysis - Product Thumbnail Image Special Offer Sale Banner

Global Oncology Market - Trends, Forecast and Pipeline Analysis

Cancer, with a death toll exceeding that of AIDS (Acquired Immune Deficiency Syndrome), tuberculosis and malaria collectively, accounted for 8.3 million deaths in 2013. With a skyrocketing incidence...

November 2014
FROM

Global Oncology Biosimilars Market 2014-2018

About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have...

November 2014
FROM
Gastric Cancer - Pipeline Review, H2 2014 Gastric Cancer - Pipeline Review, H2 2014 - Product Thumbnail Image

Gastric Cancer - Pipeline Review, H2 2014

Gastric Cancer - Pipeline Review, H2 2014 Summary This, ‘Gastric Cancer - Pipeline Review, H2 2014’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM
Recurrent Malignant Glioma - Pipeline Review, H2 2014 Recurrent Malignant Glioma - Pipeline Review, H2 2014 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Review, H2 2014

Recurrent Malignant Glioma - Pipeline Review, H2 2014 Summary This, ‘Recurrent Malignant Glioma - Pipeline Review, H2 2014’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline. This...

November 2014
FROM

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline. This...

November 2014
FROM

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

November 2014
FROM
Colorectal Cancer - Pipeline Review, H2 2014 Colorectal Cancer - Pipeline Review, H2 2014 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H2 2014

Colorectal Cancer - Pipeline Review, H2 2014 Summary This, ‘Colorectal Cancer - Pipeline Review, H2 2014’, provides an overview of the Colorectal Cancer’s therapeutic pipeline. This report provides...

November 2014
FROM

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014 Summary This, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2014’, provides an overview of the Human papillomavirus...

November 2014
FROM
Pancreatic Cancer - Pipeline Review, H2 2014 Pancreatic Cancer - Pipeline Review, H2 2014 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2014

Pancreatic Cancer - Pipeline Review, H2 2014 Summary This, ‘Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This report provides...

November 2014
FROM

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014 Summary This, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014’, provides an overview of the Relapsed Acute Myeloid Leukemia’s...

November 2014
FROM

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014 Summary This, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014’, provides an overview of the Refractory Acute Myeloid Leukemia’s...

November 2014
FROM

Breast Cancer - Pipeline Review, H2 2014

Breast Cancer - Pipeline Review, H2 2014 Summary This, ‘Breast Cancer - Pipeline Review, H2 2014’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 - Product Thumbnail Image

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Summary This, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014’, provides an overview of the...

November 2014
FROM
Liposarcoma - Pipeline Review, H2 2014 Liposarcoma - Pipeline Review, H2 2014 - Product Thumbnail Image

Liposarcoma - Pipeline Review, H2 2014

Liposarcoma - Pipeline Review, H2 2014 Summary This, ‘Liposarcoma - Pipeline Review, H2 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM
Competitor Analysis: Cancer Peptides Competitor Analysis: Cancer Peptides - Product Thumbnail Image

Competitor Analysis: Cancer Peptides

The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer....

November 2014
FROM

Immune Checkpoint Inhibitors Market, 2014 - 2024

Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to...

November 2014
FROM
Ovarian Cancer Pipeline Highlights - 2015 Ovarian Cancer Pipeline Highlights - 2015 - Product Thumbnail Image

Ovarian Cancer Pipeline Highlights - 2015

The latest report Ovarian Cancer Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Ovarian Cancer market. It covers emerging therapies for Ovarian...

November 2014
FROM
Melanoma Pipeline Highlights - 2015 Melanoma Pipeline Highlights - 2015 - Product Thumbnail Image

Melanoma Pipeline Highlights - 2015

The latest report Melanoma Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Melanoma market. It covers emerging therapies for Melanoma in active...

November 2014
FROM
Loading Indicator

Our Clients

Our clients' logos